Aberdeen Group plc boosted its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 0.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,839,680 shares of the company's stock after buying an additional 26,441 shares during the quarter. Procter & Gamble makes up about 0.8% of Aberdeen Group plc's portfolio, making the stock its 14th biggest position. Aberdeen Group plc owned about 0.12% of Procter & Gamble worth $449,763,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Benjamin Edwards Inc. raised its stake in shares of Procter & Gamble by 120.7% during the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company's stock worth $62,098,000 after purchasing an additional 199,258 shares in the last quarter. Capital Investment Advisory Services LLC raised its stake in shares of Procter & Gamble by 13.8% during the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock worth $6,426,000 after purchasing an additional 4,562 shares in the last quarter. World Investment Advisors raised its stake in shares of Procter & Gamble by 6.0% during the 1st quarter. World Investment Advisors now owns 50,913 shares of the company's stock worth $8,677,000 after purchasing an additional 2,886 shares in the last quarter. Concurrent Investment Advisors LLC raised its stake in shares of Procter & Gamble by 26.4% during the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company's stock worth $20,451,000 after purchasing an additional 25,059 shares in the last quarter. Finally, Diversify Wealth Management LLC raised its stake in shares of Procter & Gamble by 10.3% during the 1st quarter. Diversify Wealth Management LLC now owns 23,719 shares of the company's stock worth $3,849,000 after purchasing an additional 2,210 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on PG. UBS Group dropped their price objective on Procter & Gamble from $180.00 to $176.00 and set a "buy" rating on the stock in a research note on Wednesday. Barclays decreased their target price on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. BNP Paribas reissued an "outperform" rating and set a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. Berenberg Bank boosted their target price on Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a report on Wednesday, September 17th. Finally, Weiss Ratings reissued a "hold (c+)" rating on shares of Procter & Gamble in a report on Wednesday. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $172.21.
Get Our Latest Report on Procter & Gamble
Procter & Gamble Stock Performance
Shares of NYSE PG opened at $149.69 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The stock's fifty day moving average price is $155.24 and its two-hundred day moving average price is $159.53. Procter & Gamble Company has a one year low of $149.45 and a one year high of $180.43. The firm has a market cap of $350.34 billion, a price-to-earnings ratio of 22.99, a P/E/G ratio of 3.99 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same period in the prior year, the firm posted $1.40 EPS. The company's revenue for the quarter was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, insider Marc S. Pritchard sold 9,849 shares of the company's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider directly owned 182,422 shares of the company's stock, valued at $28,689,507.94. This represents a 5.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Gary A. Coombe sold 10,194 shares of the company's stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer directly owned 34,978 shares in the company, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by company insiders.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.